Human Recombinant CCL2 (MCP-1) (from E. coli)

Supplier: CHEMOTACTICS, INC MS

CCL2-100UG CCL2-1MG CCL2-50UG
MSPP-CCL2100UGEA 761.56 CAD
MSPP-CCL2100UG MSPP-CCL21MG MSPP-CCL250UG
Human Recombinant CCL2 (MCP-1) (from E. coli)
Proteins and Peptides

Recombinant Human CCL2 (MCP-1) in lyopholized format with very low endotoxin levels.


  • Extremely low endotoxin levels (<0.01 EU per 1 μg)
  • Functional activity tested and validated
  • For use in various streptavidin applications: Flow cytometry, microscopy, and other imaging techniques


Monocyte chemoattractant protein-1 (MCP-1) (CCL2) is produced by many cell types at sites of inflammation. It regulates chemotaxis and transendothielial migration of monocytes, as well as memory T cells and natural killer cells by interacting with their membrane surface receptor CCR2. MCP-1 has also been implicated in a number of disease states, such as rheumatoid arthritis, atherosclerosis, autoimmune diseases, tumor progression, and HIV infection.


Ordering information: Larger sizes available, please request a custom quote.


Delivery information: Shipped lyophilized at room temperature.


Caution: For research use only, not for use in humans.

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR